Peru is the LatAm intact-norm / elective-medical case (extends Brazil/Mexico/Argentina): circumcision is uncommon (~3.7% Morris 2016) and culturally foreign — no religious/infant tradition, intact is the norm; what exists is THERAPEUTIC (phimosis/paraphimosis/recurrent infection via MINSA/EsSalud) or private elective. Fits the regional pattern (Brazil 1.3%/Colombia 4.2%/Mexico 15.4%).
THE DISTINCTIVE BIT: Peru carries the set's MOST CONCENTRATED HIV epidemic — <1% general pop but MSM ~10–22% and TRANSGENDER WOMEN ~20–30% (41.5% among young TW 16–24 in Lima), MSM/TW >50–60% of cases — driven by anal-sex/key-population networks where the heterosexual VMMC evidence base does NOT apply. So circ plays NO role (low-circ, non-VMMC country); Peru is in effect a natural rebuttal to circumcision-as-HIV-shield. Private-clinic HIV-protection marketing line EXCLUDED as unsupported. No circ-specific statute (medical-indication-only coverage inferred from MINSA/EsSalud). NO verified Peru-specific male-circ harm case (honest gap; 0 incidents). FGC essentially absent (reported only among Shipibo-Conibo, female) — disambiguation only, kept STRICTLY separate; "geographic containment" claim NOT sustained.
Switch to the in-depth article for the full picture and sources (#531–538).
In Peru, almost no one is circumcised — and the country's HIV epidemic, one of the most concentrated in Latin America, has nothing to do with that. Circumcision here is culturally foreign: there is no religious rite, no infant routine, just the occasional surgeon treating a stubborn foreskin. Meanwhile HIV burns through specific communities — men who have sex with men, and transgender women above all — at rates that dwarf the general population. Peru is the intact-norm case that quietly dismantles the circumcision-as-HIV-shield story: the epidemic is real and severe, and the procedure is simply beside the point.
The sources here are numbered references (#531–538) in the references library and against the Peru country profile. (Female genital cutting is essentially absent in Peru and is kept strictly separate; nothing here concerns it.)
An intact country
At about 3.7% (Morris 2016), Peru sits near the bottom of the world's circumcision tables, in the company of its neighbours — Brazil at 1.3%, Colombia at 4.2%, Mexico at 15.4%. In a Catholic-heritage society with no circumcising religious majority, the intact penis is simply the norm; circumcision is something most Peruvian men never encounter. (The 3.7% is a modelled estimate — but notably, a low number cuts against the bias of the advocacy-aligned researcher who produced it, and independent work agrees circumcision is "relatively uncommon" in Peru.) What circumcision does happen falls to tiny Jewish and Muslim minorities, or to the operating table.
A treatment, not a tradition
Where Peruvians do get circumcised, it is medicine, not ritual. Peruvian urologists and the public system (MINSA, EsSalud) frame circumcision as a therapeutic operation for phimosis, paraphimosis and recurrent foreskin infection — and an Infobae health piece, citing the ministries, states plainly that circumcision "does not form part of the routine protocol in the public health system, except where there are problems such as phimosis or recurrent infections." Private clinics in Lima add a small elective dimension, offering it "by personal choice or family preference." (Those same clinic pages also market an HIV-protection benefit — a claim that does not hold in Peru's context, and which we do not endorse.) There is no infant routine, no festival, no rite of passage. It is a surgery for a problem.
The epidemic that proves the point
And here is what makes Peru worth studying. Its HIV epidemic is among the most sharply concentrated in the region: under 1% in the general population, but roughly 10–22% among men who have sex with men, and 20–30% among transgender women — reaching an extraordinary 41.5% among young trans women aged 16–24 in Lima. Those two groups account for more than half of all cases. This is an epidemic that travels through anal-sex transmission networks among key populations — precisely the setting where the circumcision-and-HIV evidence, built on adult heterosexual female-to-male transmission in Africa, simply does not apply. Peru is not a VMMC country and never has been, and no serious public-health voice proposes circumcision as a tool here. The severity of Peru's epidemic alongside its near-total absence of circumcision is, in effect, a natural rebuttal to the idea that circumcision is a general HIV shield.
No law, no cases
Peru has no statute specific to male circumcision — unsurprising for a procedure this rare and this medicalised; the medical-indication-only character of public coverage is inferred from how MINSA and EsSalud describe it rather than from any dedicated law. And in honesty, no verified Peru-specific harm case surfaced in the research — which fits a country where circumcision is uncommon and done in clinical settings, though absence of a located case is not the same as proof of safety. (Female genital cutting is essentially absent in Peru, reported only among one Amazonian group, the Shipibo-Conibo; it is a separate, female practice and we keep it rigorously apart.)
The honest bottom line
Peru is the intact-norm / elective-medical case, and its real contribution is the contrast it draws: a country that barely circumcises, carrying a severe but tightly concentrated HIV epidemic that circumcision could never have touched. It is a useful corrective to the loudest claim made for the procedure — because here the epidemic and the foreskin live side by side, and one has nothing to do with the other.
Compiled from a June 2026 deep-research pass: prevalence (Morris et al. 2016, ~3.7%, flagged as modelled; PLOS One — "relatively uncommon"); the therapeutic/elective framing (MINSA/EsSalud via Infobae; Lima clinic pages); the concentrated HIV epidemic (Peru HIV reviews; Silva-Santisteban et al. 2024 — young trans women 41.5%); and the no-circ-role finding. The 3.7% is a modelled estimate; "no statute" is absence-of-evidence (medical-indication-only coverage inferred, not from a located law); private-clinic HIV-protection marketing claims are excluded as unsupported; no verified Peruvian male-circ harm case was found (honest gap); circumcision plays no role in an anal-sex/key-population epidemic and no circ–HIV claim is made; FGC is essentially absent (reported only among the Shipibo-Conibo) and kept strictly separate, and a claim of its geographic containment was not sustained. See references #531–538.
